GB0016426D0 - Pharmaceutical combination - Google Patents

Pharmaceutical combination

Info

Publication number
GB0016426D0
GB0016426D0 GBGB0016426.9A GB0016426A GB0016426D0 GB 0016426 D0 GB0016426 D0 GB 0016426D0 GB 0016426 A GB0016426 A GB 0016426A GB 0016426 D0 GB0016426 D0 GB 0016426D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical combination
pharmaceutical
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0016426.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0016426.9A priority Critical patent/GB0016426D0/en
Publication of GB0016426D0 publication Critical patent/GB0016426D0/en
Priority to PCT/SE2001/001545 priority patent/WO2002002107A1/en
Priority to AU2001268000A priority patent/AU2001268000A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0016426.9A 2000-07-05 2000-07-05 Pharmaceutical combination Ceased GB0016426D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0016426.9A GB0016426D0 (en) 2000-07-05 2000-07-05 Pharmaceutical combination
PCT/SE2001/001545 WO2002002107A1 (en) 2000-07-05 2001-07-04 Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition
AU2001268000A AU2001268000A1 (en) 2000-07-05 2001-07-04 Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016426.9A GB0016426D0 (en) 2000-07-05 2000-07-05 Pharmaceutical combination

Publications (1)

Publication Number Publication Date
GB0016426D0 true GB0016426D0 (en) 2000-08-23

Family

ID=9895013

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0016426.9A Ceased GB0016426D0 (en) 2000-07-05 2000-07-05 Pharmaceutical combination

Country Status (3)

Country Link
AU (1) AU2001268000A1 (en)
GB (1) GB0016426D0 (en)
WO (1) WO2002002107A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121152A1 (en) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "USE OF THE COMBINATION OF AN AROMATASE INHIBITOR WITH AN ANTIANDROGEN FOR PROPHYLAXIS AND THERAPY OF PROSTATE HYPERPLASIA"
ATE28864T1 (en) * 1982-07-23 1987-08-15 Ici Plc AMIDE DERIVATIVES.
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
EP0748220A4 (en) * 1994-01-21 1997-09-10 Sepracor Inc Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia

Also Published As

Publication number Publication date
AU2001268000A1 (en) 2002-01-14
WO2002002107A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
GB0006133D0 (en) Novel pharmaceutical
GB0020691D0 (en) Pharmaceutical combination
GB0025473D0 (en) Pharmaceutical combinations
GB0031084D0 (en) Pharmaceutical compounds
GB0012291D0 (en) Pharmaceutical combination
GB0019228D0 (en) Novel pharmaceutical
GB0021865D0 (en) Novel pharmaceutical
GB0019272D0 (en) Pharmaceutical compounds
GB0014006D0 (en) Novel pharmaceutical
GB0024318D0 (en) Pharmaceutical compounds
GB0019226D0 (en) Novel pharmaceutical
GB0019224D0 (en) Novel pharmaceutical
GB0021487D0 (en) Pharmaceutical
GB0014005D0 (en) Novel pharmaceutical
GB0023971D0 (en) Novel pharmaceutical
GB0005366D0 (en) Pharmaceutical compounds
GB0012293D0 (en) Pharmaceutical combination
GB0021785D0 (en) Novel Pharmaceutical
GB0019223D0 (en) Novel pharmaceutical
GB0023970D0 (en) Novel pharmaceutical
GB0017666D0 (en) Pharmaceutical combination
GB0016429D0 (en) Pharmaceutical combination
GB0016428D0 (en) Pharmaceutical combination
GB0016427D0 (en) Pharmaceutical combination
GB0020767D0 (en) Pharmaceutical combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)